Angioimmunoblastic T-cell Lymphoma
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Angioimmunoblastic T-cell Lymphoma

What is the definition of Angioimmunoblastic T-cell Lymphoma?
Angioimmunoblastic T-cell lymphoma (AITL) is a rare, aggressive type of non-Hodgkin lymphoma or peripheral T-cell lymphoma (PTCL), which is a cancer that affects the lymphatic system. The lymphatic system and white blood cells are part of the immune system that helps protect the body against infection and disease. Lymphomas involve cancer of the white blood cells (lymphocytes) and are classified by the type of white blood cells involved: either B-lymphocytes (B-cells) or T-lymphocytes (T-cells). In angioimmunoblastic T-cell lymphoma, a T-cell transforms into a malignant (cancerous) cell that leads to a dysfunction of the immune system. Angioimmunoblastic T-cell lymphoma mainly affects the elderly.
What are the symptoms of Angioimmunoblastic T-cell Lymphoma?
Symptoms of angioimmunoblastic T-cell lymphoma may include an enlargement of the lymph nodes and other lymphatic organs, such as the spleen and bone marrow; fatigue; pale skin; dark urine; malaise; persistent high fever; night sweats; unintended weight loss; edema (swelling); pleural effusion (fluid around lungs); shortness of breath; rapid heartbeat; abdominal fluid (ascites); rash; itching; liver enlargement; bruising; vasculitis (inflammation of blood vessels); neurological abnormalities, such as confusion, apathy, tinnitus (ringing in the ears), nerve inflammation (polyneuritis), eye swelling, and hearing or visual impairment; gastrointestinal abnormalities, such as ulcers, diarrhea, gastrointestinal bleeding, and intestinal polyps, inflammation of the bile ducts; and autoimmune disorders, such as autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (low platelets; ITP).
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Angioimmunoblastic T-cell Lymphoma?
Some patients with angioimmunoblastic T-cell lymphoma may not initially receive treatment as their doctor may take a wait-and-watch approach until the cancer progresses. Treatment for aggressive angioimmunoblastic T-cell lymphoma includes combined chemotherapy, such as cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) or doxorubicin, vincristine, cyclophosphamide, etoposide, and prednisone (CHOEP); radiation therapy; higher doses of chemotherapy, followed by stem cell transplantation; corticosteroids; and multidrug chemotherapy at the end of treatment. In patients with angioimmunoblastic T-cell lymphoma with a CD30 marker on cancer cells, brentuximab vedotin (Adcetris) may be used in combination with cyclophosphamide, doxorubicin, and prednisone. Since relapse is common for angioimmunoblastic T-cell lymphoma, or for patients who are resistant to treatment, romidepsin (Istodax), belinostat (Beleodaq), or pralatrexate (Folotyn) may be administered. Other treatments following relapse may include high-dose chemotherapy followed by an autologous (patient’s) stem cell transplant or an allogeneic (donor) stem cell transplant. Additional drugs that may be used include enalidomide (Revlimid) alone or in combination with current chemotherapy regimens. Drugs used for other types of lymphoma may also be used for patients with angioimmunoblastic T-cell lymphoma, such as gemcitabine (Gemzar), bortezomib (Velcade), bendamustine (Treanda), or alemtuzumab (Campath).
Who are the top Angioimmunoblastic T-cell Lymphoma Local Doctors?
Elite in Angioimmunoblastic T-cell Lymphoma
Elite in Angioimmunoblastic T-cell Lymphoma
Referral may be required
Tsukuba, JP 

Mamiko Yanagimoto-Sakata practices practicing medicine in Tsukuba, Japan. Ms. Yanagimoto-Sakata is rated as an Elite expert by MediFind in the treatment of Angioimmunoblastic T-cell Lymphoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Bone Marrow Transplant, and Bone Graft.

Elite in Angioimmunoblastic T-cell Lymphoma
Elite in Angioimmunoblastic T-cell Lymphoma
Referral may be required
Lyon, FR 

Emmanuel Bachy practices practicing medicine in Lyon, France. Mr. Bachy is rated as an Elite expert by MediFind in the treatment of Angioimmunoblastic T-cell Lymphoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Kidney Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Angioimmunoblastic T-cell Lymphoma
Hematology | Oncology
Distinguished in Angioimmunoblastic T-cell Lymphoma
Hematology | Oncology
Referral may be required

Fred & Pamela Buffett Cancer Center - Nebraska Medical Center

505 S 45th St., 
Omaha, NE 
Languages Spoken:
English, American Sign Language
Accepting New Patients
Offers Telehealth

Julie Vose is a Hematologist and an Oncologist practicing medicine in Omaha, Nebraska. Dr. Vose is rated as a Distinguished provider by MediFind in the treatment of Angioimmunoblastic T-cell Lymphoma. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Vose is currently accepting new patients.

What are the latest Angioimmunoblastic T-cell Lymphoma Clinical Trials?
A Randomized Phase II Study of CHO(E)P vs CC-486-CHO(E)P vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas

Summary: This phase II trial studies the effect of duvelisib or CC-486 and usual chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone in treating patients with peripheral T-cell lymphoma. Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, doxorubicin, vincrist...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Carolina Senior: UNC Registry for Older Cancer Patients

Summary: RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.